Cost-effectiveness of laparoscopy versus laparotomy for initial surgical evaluation and treatment of potentially resectable hepatic colorectal metastases: A decision analysis

Journal of Surgical Oncology

Volumn 97, Issue 5, 2008, Pages 396-403

  Karuna, Shelly Tanner ^a   Thirlby, Richard ^a   Biehl, Thomas ^a   Veenstra, David ^b  

^a VIRGINIA MASON MEDICAL CENTER   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Colorectal cancer; Cost effectiveness; Decision analysis; Hepatic metastases; Laparoscopy

Indexed keywords

ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CANCER SURGERY; COLORECTAL CANCER; COMPARATIVE STUDY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; DECISION TREE; HEALTH CARE COST; HUMAN; LAPAROSCOPY; LAPAROTOMY; LIVER METASTASIS; LIVER RESECTION; MAJOR CLINICAL STUDY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; SENSITIVITY ANALYSIS; VALIDITY;

COLORECTAL NEOPLASMS; COST-BENEFIT ANALYSIS; DECISION TREES; HOSPITALIZATION; HUMANS; LAPAROSCOPY; LAPAROTOMY; LIVER NEOPLASMS; QUALITY-ADJUSTED LIFE YEARS; SURVIVAL ANALYSIS; UNITED STATES;

EID: 41549135236     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.20964     Document Type: Article

References (40)

1. Penna C, Nordlinger B: Colorectal metastasis (liver and lung). Surg Clin N Am 2002;82:1075-1090.
2. Sabin LH, Wittekind CH, editors. UICC TNM classification of malignant tumours, 6th edition. New York: Wiley; 2002.
3. Fahy B, Jarnagin W: Evolving techniques in the treatment of liver colorectal metastases: Role of laparoscopy, radiofrequency ablation, microwave coagulation, hepatic arterial chemotherapy, indications and contraindications for resection, role of transplantation, and timing of chemotherapy. Surg Clin N Am 2006;86:1005-1022.
4. Bentrem D, DeMatteo R: Blumgart: Surgical therapy for metastatic disease to the liver. Annu Rev Med 2005;56:139-156.
5. Lewis A, Martin R: The treatment of hepatic metastases in colorectal carcinoma. Am Surg 2006;72:466-473.
6. Selzner M, Hany T, Wildbrett P, et al.: Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver? Ann Surg 2004;240:1027-1036.
7. Langenhoff BS, Krabbe PFM, Peerenboom L, et al.: Quality of life after surgical treatment of colorectal liver metastases. Br J Surg 2006;93:1007-1014.
8. Poon RT, Fan ST, Yu WC, et al.: A prospective longitudinal study of quality of life after resection of hepatocellular carcinoma. Arch Surg 2001;136:693-699.
9. Grobmyer S, Fong Y, D'Angelica M, et al.: Diagnostic laparoscopy prior to planned hepatic resection for colorectal metastases. Arch Surg 2004;139:1326-1330.
10. Rahusen F, Cuesta M, Borgstein P, et al.: Selection of patients for resection of colorectal metastases to the liver using diagnostic laparoscopy and laparoscopic ultrasound. Ann Surg 1999;230: 31-37.
11. Thaler K, Kanneganti S, Khajanchee Y, et al.: The evolving role of staging laparoscopy in the treatment of colorectal hepatic metastasis. Arch Surg 2005;140:727-734.
12. Jarnagin W, Conlon K, Bodniewicz J, et al.: A clinical scoring system predicts the yield of diagnostic laparoscopy in patients with potentially resectable hepatic colorectal metastases. Cancer 2001;91:1121-1128.
13. Jarnagin W, Fong Y, Ky A, et al.: Liver resection for metastatic colorectal cancer: Assessing the risk of occult irresectable disease. J Am Coll Surg 1999;188:33-42.
14. Gazelle GS, Hunink MGM, Kuntz KM, et al.: Cost-effectiveness of hepatic metastasectomy in patients with metastatic colorectal carcinoma: A state-transition Monte Carlo decision analysis. Ann Surg 2003;237:544-555.
15. Beard SM, Holmes M, Price C, et al.: Hepatic resection for colorectal liver metastases: A cost-effectiveness analysis. Ann Surg 2000;232:763-776.
16. Gold MR, Siegel JE, Russell LB, et al.: Cost-effectiveness in health and medicine. New York: Oxford University Press; 1996.
17. Belghiti J, Hiramatsu K, Benoist S, et al.: Seven hundred forty-seven hepatectomies in the 1990s: An update to evaluate the actual risk of liver resection. J Am Coll Surg 2000;191:38-46.
18. Metcalfe MS, Close JR, Iswariah H, et al.: The value of laparoscopic staging for patients with colorectal metastases. Arch Surg 2003;138:770-772.
19. Koea J, Rodgers M, Thompson P, et al.: Laparoscopy in the management of colorectal cancer metastatic to the liver. ANZ J Surg 2004;74:1056-1059.
20. Simmonds PC, Primrose JN, Colquitt JL, et al.: Surgical resection of hepatic metastases from colorectal cancer: A systematic review of published studies. Br J Cancer 2006;94:982-999.
21. Pol B, Campan P, Hardwigsen J, et al.: Morbidity of major hepatic resections: A 100-case prospective study. Eur J Surg 1999; 165:446-453.
22. Dimick JB, Provonost PJ, Cowan JA, et al.: Postoperative complication rates after hepatic resection in Maryland hospitals. Arch Surg 2003;138:41-46.
23. Fong Y, Cohen AM, Fortner JG, et al.: Liver resection for colorectal metastases. J Clin Oncol 1997;15:938-946.
24. Benzoni E, Cojutti A, Lorenzin D, et al.: Liver resective surgery: A multivariate analysis of postoperative outcome and complication. Lang Arch Surg 2007;392:45-54.
25. Memon MA, Beckingham IJ: Surgical resection of colorectal liver metastases. Colorectal Dis 2001;3:361-373.
26. Cummings LC, Payes JD, Cooper GS: Survival after hepatic resection in metastatic colorectal cancer. Cancer 2007;109:718-726.
27. Choti MA, Sitzmann JV, Tiburi MF, et al.: Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 2002;235:759-766.
28. Stewart GD, O'Suilleabhain CB, Madhavan KK, et al.: The extent of resection influences outcome following hepatectomy for colorectal liver metastases. Eur J Surg Oncol 2004;30:370-376.
29. Fernandez FG, Drebin JA, Linehan DC, et al.: Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET). Ann Surg 2004;240:438-450.
30. Manfredi S, Lepage C, Hatem C, et al.: Epidemiology and management of liver metastases from colorectal cancer. Ann Surg 2006;244:254-259.
31. Fryback DG, Dasbach EJ, Klein R, et al.: The beaver dam health outcomes study: Initial catalog of health-state quality factors. Med Decis Making 1993;13:89-102.
32. Wagner JS, Adson MA, Van Heerden JA, et al.: The natural history of hepatic metastases from colorectal cancer: A comparison with resective treatment. Ann Surg 1984;199:502-508.
33. Steele G, Bleday R, Mayer RJ, et al.: A prospective evaluation of hepatic resection for colorectal carcinoma metastases to the liver: Gastrointestinal tumor study group protocol 6584. J Clin Oncol 1991;9:1105-1112.
34. Truant S, Huglo D, Hebbar M, et al.: Prospective evaluation of the impact of [18F]Fluoro-2-deoxy-D-glucose positron emission tomography of resectable colorectal liver metastases. Br J Surg 2005;92:362-369.
35. Yang M, Martin DR, Karabulut N, et al.: Comparison of MRI and PET imaging for the evaluation of liver metastases. J Magn Reson Imaging 2003;17:343-349.
36. Joyce DL, Wahl RL, Patel PV, et al.: Preoperative positron emission tomography to evaluate potentially resectable hepatic colorectal metastases. Arch Surg 2006;141:1220-1226.
37. Ertuk SM, Ichikawa T, Fujii H, et al.: PET imaging for evaluation of metastatic colorectal cancer of the liver. Eur J Rad 2006;58:229-235.
38. Wiering B, Krabbe PFM, Jager GJ, et al.: The impact of Fluor-18-deoxyglucose-positron emission tomography in the management of colorectal liver metastases: A systematic review and metaanalysis. Cancer 2005;104:2658-2670.
39. Arulampalam THA, Francis DL, Visvikis D, et al.: FDG-PET for the pre-operative evaluation of colorectal liver metastases. Eur J Surg Oncol 2004;30:286-291.
40. Akhurst T, Kates T, Mazumdar M, et al.: Recent chemotherapy reduces the sensitivity of [18F]fluorodeoxyglucose positron emission tomography in the detection of colorectal metastases. J Clin Onc 2005;23:8713-8716.